提升肝動脈人工血管植入流程照護之完整率

Enhance the Completion Rate with Port-A Implantation of Hepatic Artery Care Process

陳璵帆(Yu-Fan Chen) ； 梁博欽(Po-Chin Liang) ； 陳幼貴(Yu-Kuei Chen)

《台灣醫學》 22卷4期 (2018/07) Pp. 428-437

https://doi.org/10.6320/FJM.201807_22(4).0011

摘要

肝動脈人工血管植入及灌注化療是晚期肝癌病人獨特性治療，病人接受植入術後可能會有出血、皮下血腫、感染及導管尖端錯位等併發症，而延遲治療影響腫瘤控制。本專案經現況分析發現腫瘤病房肝動脈人工血管植入流程照護完整率低（55.6%），主要原因包括未建置照護準則、住院醫師每月輪替、無肝動脈人工血管植入流程相關參考資料或工具、不清楚肝動脈人工血管植入流程與照護準則，以及人員疏忽忘記等引發專案小組改善動機，藉由制定肝動脈人工血管植入流程照護準則、查檢表、技術評核，錄製衛教影片及協助團隊醫師建置診療醫令套餐，提升肝動脈人工血管植入流程照護之完整率到91.2%有效減少肝動脈人工血管植入術後的併發症，提升照護品質。

關鍵字

肝動脈 ； 人工血管 ； 植入流程照護

並列摘要

Hepatic arterial catheter implantation and hepatic arterial infusion chemotherapy are the specific treatments for advanced stage liver cancer patients. The common complications after catheter implantation include hemorrhage, hematoma, infection and dislocation of catheter tip. These might delay treatment and tumor control. The study showed that completion rate with port-A implantation of hepatic artery care was 55.6%. The major reasons were unbuilt nursing guidelines, the monthly change-of-shift of the attending physician, and the lack of hepatic arterial catheter implantation. The improving strategies include establish the standardized protocol of hepatic arterial catheter implantation, make checklists, skill evaluation, make instructional videos, built computerized physician order entry. These measures enhance the completion rate of hepatic arterial catheter implantation to 91.2%. Thus, our efforts decreased the complications and enhanced the quality of treatment management.

並列關鍵字

hepatic artery ； port-A implantation ； care process

參考文獻

劉鐘軒、蔡正中、陳海雄：肝癌的診斷及治療最新發展。內科學誌 2013;24:85-94。[Liu CH, Tsai CC, Chen HH: Diagnosis and treatment strategy of hepatocellular carcinoma. Taiwan Society of Internal Medicine 2013; 24: 85-94.] doi: 10.6840/CYCU.2013.00103

黃璉華、黃嗣棻：病人安全是醫療照護之首要。護理雜誌 2013;60:13-8。[Huang LH, Huang SF: Patient safety as the first priority in healthcare. The Journal of Nursing 2013;60:13-8.]

Terashima T, Yamashita T, Arai K, et al: Response to chemotherapy improves hepatic reserve for patients with hepatocellular carcinoma and Child–Pugh B cirrhosis. Cancer Sci 2016;107:1263-9. doi: 10.1111/cas.12992

Obi S, Sato S, Kawai T: Current status of hepatic arterial infusion chemotherapy. Liver Cancer 2015;4:188-99. doi: 10.1159/000367746

Paul SB, Sharma H: Role of transcatheter intra-arterial therapies for hepatocellular carcinoma. J Clin Exp Hepatol 2014;4:112-21. doi: 10.1016/j.jceh.2014.03.048